Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-01 00:00:00 ET · period of report 2022-01-28 · accession 0001209191-22-005895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-01 | 2022-01-28 | VRTX | MCGLYNN MARGARET G | Dir | S - Sale+OE | $241.79 | -5,000 | 4,198 | -54% | -$1.21M |
| D | 2022-02-01 | 2022-01-28 | VRTX | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | +5,000 | 6,099 | +455% | +$637.7K |
| D | 2022-02-01 | 2022-01-28 | VRTX | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | -5,000 | 15.0K | -25% | -$637.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-28 | S | D | 800 | $241.83 | 3,398 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $241.83 (range $241.16 to $242.15). |
| 2 | Common | Common Stock | 2022-01-28 | S | D | 212 | $243.24 | 1,099 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $243.24 (range $243.21 to $243.27). |
| 3 | Common | Common Stock | 2022-01-28 | S | D | 2,087 | $242.78 | 1,311 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $242.78 (range $242.18 to $243.14). |
| 4 | Common | Common Stock | 2022-01-28 | M | A | 5,000 | $127.54 | 6,099 | D | — | — | |
| 5 | Common | Common Stock | 2022-01-28 | S | D | 1,901 | $240.53 | 4,198 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $240.53 (range $240.01 to $240.92). |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-28 | M | D | 5,000 | $127.54 | 15,000 | D | $127.54 · — to 2025-05-31 | 5,000 Common Stock | (F7) Fully vested. |